DIAMOND HILL CAPITAL MANAGEMENT INC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.

Quarter-by-quarter ownership
DIAMOND HILL CAPITAL MANAGEMENT INC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2017$717,000
+45.1%
34,5000.0%0.00%
+33.3%
Q3 2017$494,000
-17.3%
34,5000.0%0.00%0.0%
Q2 2017$597,000
+56.7%
34,5000.0%0.00%
+50.0%
Q1 2017$381,000
-24.0%
34,5000.0%0.00%
-33.3%
Q4 2016$501,000
-94.1%
34,500
-90.0%
0.00%
-94.3%
Q3 2016$8,503,000
-24.3%
346,336
-37.9%
0.05%
-25.4%
Q2 2016$11,237,000
-25.2%
557,933
-2.3%
0.07%
-26.0%
Q1 2016$15,025,000
-51.0%
571,305
+89.6%
0.10%
-52.7%
Q4 2015$30,635,000
+1.3%
301,374
+77.8%
0.20%
-2.9%
Q3 2015$30,243,000
+4.2%
169,542
+29.8%
0.21%
+8.3%
Q2 2015$29,017,000
-18.6%
130,617
-27.2%
0.19%
-21.9%
Q1 2015$35,653,000
+45.3%
179,505
+4.7%
0.25%
+41.1%
Q4 2014$24,545,000
+8.1%
171,513
-0.9%
0.18%0.0%
Q3 2014$22,699,000
+21.7%
173,012
+17.0%
0.18%
+19.0%
Q2 2014$18,649,000
+381.6%
147,867
+403.5%
0.15%
+345.5%
Q1 2014$3,872,000
+605.3%
29,370
+528.2%
0.03%
+560.0%
Q4 2013$549,000
+43.3%
4,675
+27.2%
0.01%
+25.0%
Q3 2013$383,000
+36.8%
3,675
+13.1%
0.00%
+33.3%
Q2 2013$280,0003,2500.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2015
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders